MyD88-dependent activation of dendritic cells and CD4+ T lymphocytes mediates symptoms, but is not required for the immunological control of parasites during rodent malaria

Microbes and Infection

Volumn 9, Issue 7, 2007, Pages 881-890

  Franklin, Bernardo S ^a   Rodrigues, Soraia O ^a,b   Antonelli, Lis R ^b   Oliveira, Roberta V ^a,b   Goncalves, Arthur M ^b   Sales Junior, Policarpo A ^a,b,c   Valente, Eneida P ^b   Alvarez Leite, Jacqueline I ^b   Ropert, Catherine ^a   Golenbock, Douglas T ^d   Gazzinelli, Ricardo T ^a,b,d  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c Santa Casa de Misericordia de Goiania   (Brazil)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Cytokines; Innate immunity; Malaria and Plasmodium chabaudi; Pathogenesis; Toll like receptors

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; CD4 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HOST RESISTANCE; INFECTION RESISTANCE; INNATE IMMUNITY; INTERFERON PRODUCTION; MALARIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; DENDRITIC CELLS; FLOW CYTOMETRY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; MALARIA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; PARASITEMIA; PLASMODIUM CHABAUDI; SPLEEN; TOLL-LIKE RECEPTORS;

ANIMALIA; MUS; PLASMODIUM CHABAUDI; PLASMODIUM CHABAUDI CHABAUDI; RODENTIA;

EID: 34249995688     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2007.03.007     Document Type: Article

References (30)

1. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
2. Muroi M., Ohnishi T., and Tanamoto K. Regions of the mouse CD14 molecule required for toll-like receptor 2- and 4-mediated activation of NF-kappa B. J. Biol. Chem. 277 (2002) 42372-42379
3. Gazzinelli R.T., and Denkers E.Y. Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism. Nat. Rev. Immunol. 6 (2006) 895-906
4. Pasare C., and Medzhitov R. Toll-dependent control mechanisms of CD4 T cell activation. Immunity 21 (2004) 733-741
5. Stevenson M.M., and Riley E.M. Innate immunity to malaria. Nat. Rev. Immunol. 4 (2004) 169-180
6. Schofield L., and Grau G.E. Immunological processes in malaria pathogenesis. Nat. Rev. Immunol. 5 (2005) 722-735
7. Campos M.A., Almeida I.C., Takeuchi O., Akira S., Valente E.P., Procopio D.O., Travassos L.R., Smith J.A., Golenbock D.T., and Gazzinelli R.T. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J. Immunol. 167 (2001) 416-423
8. Krishnegowda G., Hajjar A.M., Zhu J., Douglass E.J., Uematsu S., Akira S., Woods A.S., and Gowda D.C. Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J. Biol. Chem. 280 (2005) 8606-8616
9. Coban C., Ishii K.J., Kawai T., Hemmi H., Sato S., Uematsu S., Yamamoto M., Takeuchi O., Itagaki S., Kumar N., Horii T., and Akira S. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J. Exp. Med. 201 (2005) 19-25
10. Parroche P., Lauw F.L., Goutagny N., Latz E., Monks B., Visintin A., Halmen K., Lamphier M., Olivier M., Bartholomeu D.C., Gazzinelli R.T., and Golenbock D.T. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 1919-1924
11. Ockenhouse C.F., Hu W.C., Kester K.E., Cummings J.F., Stewart A., Heppner D.G., Jedlicka A.E., Scott A.L., Wolfe N.D., Vahey M., and Burke D.S. Common and divergent immune response signaling pathways discovered in peripheral blood mononuclear cell gene expression patterns in presymptomatic and clinically apparent malaria. Infect. Immun. 74 (2006) 5561-5573
12. Mockenhaupt F.P., Cramer J.P., Hamann L., Stegemann M.S., Eckert J., Oh N.R., Otchwemah R.N., Dietz E., Ehrhardt S., Schroder N.W., Bienzle U., and Schumann R.R. Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 177-182
13. Mockenhaupt F.P., Hamann L., Von Gaertner C., Bedu-Addo G., Von Kleinsorgen C., Schumann R.R., and Bienzle U. Common polymorphisms of toll-like receptors 4 and 9 are associated with the clinical manifestation of malaria during pregnancy. J. Infect. Dis. 194 (2006) 184-188
14. Adachi K., Tsutsui H., Kashiwamura S., Seki E., Nakano H., Takeuchi O., Takeda K., Okumura K., Van Kaer L., Okamura H., Akira S., and Nakanishi K. Plasmodium berghei infection in mice induces liver injury by an IL-12- and toll-like receptor/myeloid differentiation factor 88-dependent mechanism. J. Immunol. 167 (2001) 5928-5934
15. Coban C., Ishii K.J., Uematsu S., Arisue N., Sato S., Yamamoto M., Kawai T., Takeuchi O., Hisaeda H., Horii T., and Akira S. Pathological role of Toll-like receptor signaling in cerebral malaria. Int. Immunol. 19 (2006) 67-79
16. Bastos K.R., Barboza R., Elias R.M., Sardinha L.R., Grisotto M.G., Marinho C.R., Amarante-Mendes G.P., Alvarez J.M., and Lima M.R. Impaired macrophage responses may contribute to exacerbation of blood-stage Plasmodium chabaudi chabaudi malaria in interleukin-12-deficient mice. J. Interferon Cytokine Res. 22 (2002) 1191-1199
17. Li C., Sanni L.A., Omer F., Riley E., and Langhorne J. Pathology of Plasmodium chabaudi chabaudi infection and mortality in interleukin-10-deficient mice are ameliorated by anti-tumor necrosis factor alpha and exacerbated by anti-transforming growth factor beta antibodies. Infect. Immun. 71 (2003) 4850-4856
18. Langhorne J., Albano F.R., Hensmann M., Sanni L., Cadman E., Voisine C., and Sponaas A.M. Dendritic cells, pro-inflammatory responses, and antigen presentation in a rodent malaria infection. Immunol. Rev. 201 (2004) 35-47
19. Scanga C.A., Aliberti J., Jankovic D., Tilloy F., Bennouna S., Denkers E.Y., Medzhitov R., and Sher A. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J. Immunol. 168 (2002) 5997-6001
20. Muraille E., De Trez C., Brait M., De Baetselier P., Leo O., and Carlier Y. Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response. J. Immunol. 170 (2003) 4237-4241
21. Campos M.A., Closel M., Valente E.P., Cardoso J.E., Akira S., Alvarez-Leite J.I., Ropert C., and Gazzinelli R.T. Impaired production of proinflammatory cytokines and host resistance to acute infection with Trypanosoma cruzi in mice lacking functional myeloid differentiation factor 88. J. Immunol. 172 (2004) 1711-1718
22. Drennan M.B., Stijlemans B., Van Den Abbeele J., Quesniaux V.J., Barkhuizen M., Brombacher F., De Baetselier P., Ryffel B., and Magez S. The induction of a type 1 immune response following a Trypanosoma brucei infection is MyD88 dependent. J. Immunol. 175 (2005) 2501-2509
23. Su Z., and Stevenson M.M. IL-12 is required for antibody-mediated protective immunity against blood-stage Plasmodium chabaudi AS malaria infection in mice. J. Immunol. 168 (2002) 1348-1355
24. Malmstrom V., Shipton D., Singh B., Al-Shamkhani A., Puklavec M.J., Barclay A.N., and Powrie F. CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID mice. J. Immunol. 166 (2001) 6972-6981
25. Sugamura K., Ishii N., and Weinberg A.D. Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40. Nat. Rev. Immunol. 4 (2004) 420-431
26. Maxwell J.R., Yadav R., Rossi R.J., Ruby C.E., Weinberg A.D., Aguila H.L., and Vella A.T. IL-18 bridges innate and adaptive immunity through IFN-gamma and the CD134 pathway. J. Immunol. 177 (2006) 234-245
27. Singh R.P., Kashiwamura S., Rao P., Okamura H., Mukherjee A., and Chauhan V.S. The role of IL-18 in blood-stage immunity against murine malaria Plasmodium yoelii 265 and Plasmodium berghei ANKA.J. Immunol. 168 (2002) 4674-4681
28. Baratin M., Roetynck S., Lepolard C., Falk C., Sawadogo S., Uematsu S., Akira S., Ryffel B., Tiraby J.G., Alexopoulou L., Kirschning C.J., Gysin J., Vivier E., and Ugolini S. Natural killer cell and macrophage cooperation in MyD88-dependent innate responses to Plasmodium falciparum. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 14747-14752
29. Mun H.S., Aosai F., Norose K., Chen M., Piao L.X., Takeuchi O., Akira S., Ishikura H., and Yano A. TLR2 as an essential molecule for protective immunity against Toxoplasma gondii infection. Int. Immunol. 15 (2003) 1081-1087
30. Bafica A., Santiago H.C., Goldszmid R., Ropert C., Gazzinelli R.T., and Sher A. Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection. J. Immunol. 177 (2006) 3515-3519